http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1868619-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36089addd8e49e968b4c7e13c517dd1c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
filingDate 2006-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf56c8e2de7a630b50a91c9fad63b19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cf20f2c7466010016f9ebe6684ceea2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cc78da8bc4050449b2b46d92b69c8e9
publicationDate 2007-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1868619-A1
titleOfInvention Use of macrolides for treating intestinal inflammation
abstract The present invention relates to a compound of formula (IA) as defined in the specification or a pharmaceutically acceptable salt thereof, in the preparation of a medicament for both the treatment of inflammatory bowel diseases and the prevention of colon cancer.
priorityDate 2005-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226444574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129058916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128681276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6959
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226418074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128358759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426079160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419567190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492594

Total number of triples: 49.